Andreas Wicki, Director at Pacira BioSciences, Inc. (PCRX), sold 344,382 shares at $70.90 ($24.8M) on 2021-03-09, disclosed to the SEC on 2021-03-11.
Open-market sale of $24.8M PCRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.90 | 35,137 | $2.5M | 10.1% |
| 2 | $70.90 | 35,137 | $2.5M | 10.1% |
| 3 | $71.78 | 76,480 | $5.5M | 22.2% |
| 4 | $71.78 | 76,480 | $5.5M | 22.2% |
| 5 | $72.70 | 60,574 | $4.4M | 17.8% |
| 6 | $72.70 | 60,574 |
| $4.4M |
| 17.8% |
| Total | $71.92 avg | 344,382 | $24.8M | 100% |
| Filing → |
| HRMY | SELL | 2022-11-16 | $6.1M | — | Filing → |
| HRMY | SELL | 2022-11-10 | $15.2M | — | Filing → |
| HRMY | SELL | 2022-11-04 | $68.2M | — | Filing → |